Image

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Comparing Guselkumab and Golimumab for PsA patients not responding to TNF.

Recruiting
18-80 years
All
Phase 3

This study looks at two treatments for psoriatic arthritis (PsA), a condition that causes joint pain and swelling. The study compares two medicines: **guselkumab** (a selective IL23 inhibitor) and **golimumab** (a TNF inhibitor). TNF inhibitors are drugs that reduce inflammation caused by a protein called tumor necrosis factor (TNF). IL23 inhibitors work differently by targeting a specific part of the immune system. The study aims to find out if switching to guselkumab helps more than switching to another TNF inhibitor when the first TNF treatment does not work well enough.

Eligibility for the study includes having active PsA, being on a stable dose of certain medications, and using or having used one TNF inhibitor before. People who have used golimumab or other specific biologic drugs before cannot join.

  • The study involves switching medications to see which works better.
  • Participants must have PsA that isn't responding well to current TNF treatment.
  • Some people may not qualify if they have used certain medications or have specific health conditions.
Study details
    Psoriatic Arthritis

NCT05669833

University of Pennsylvania

10 October 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.